Biologics in systemic autoimmune diseases

Dr Bhaskar Dasgupta is a consultant in rheumatology, head of the Rheumatology Department at Southend University Hospital (UK), and leading expert behind guidelines on polymyalgia rheumatica and giant cell arteritis.

See also

Diagnosis of inflammatory myopathies A lecture by Dr Yves Allenbach, from Sorbonne University, France, delivered at McMaster International Review Course in Internal Medicine (MIRCIM) in May 2019.
Challenges in the diagnosis of chronic immune-mediated rheumatic diseases A lecture by Dr Christian Dejaco, from Medical University of Graz, Austria, delivered at McMaster International Review Course in Internal Medicine (MIRCIM) in May 2019.
Common and rare adverse effects of biologic therapy Which common and rare adverse effects of biologic therapy should we consider during follow-up?
Classification criteria for idiopathic inflammatory myopathy What has changed in the classification criteria of idiopathic inflammatory myopathies? What subgroups of patients can be distinguished and what are the differences between them?
Classification and diagnosis of immune-mediated rheumatic diseases How can we classify immune-mediated rheumatic diseases? Why is it particularly important to diagnose and treat them early?
Biologics used in rheumatic diseases The number of indications for the use of biologic drugs in rheumatic diseases is growing. Which classes of biologics are currently used?
Giant cell arteritis and other large vessel vasculitis A lecture by Dr Bhaskar Dasgupta, from Southend University Hospital, UK, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2017.

Biologics in systemic autoimmune diseases

Social Media